News Novo completes major filings for blockbuster hope semaglutid... Novo Nordisk has its weekly diabetes hopeful semaglutide filed in five key markets, after submitting a dossier in Japan.
News Heart trial success will give Xarelto edge Xarelto aces outcomes trial and could have edge over Boehringer and BMS rivals.
News Sanofi cholesterol drug can stay on US market - for now Sales of Praluent can continue during patent case appeal.
News OECD calls for 'rebalancing of power' in drug price negotiat... Health systems should fund more treatments for chronic diseases, says EFPIA
News Court bans US sales of Sanofi cholesterol drug Amgen looks to corner PCSK9 market after patent win.
News Relief for AZ as Truqap hits the spot in prostate cancer After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
